Patients treated with dupilumab experienced fewer asthma exacerbations than the overall population.
Mobile devices may help patients with asthma better manage and control their disease.
Pediatric patients benefited from orally administered injectable dexamethasone for asthma exacerbations.
A survey that was part of the Severe Asthma Research Program found a specific subgroup of patients with asthma who have highly variable asthma control.
Montelukast therapy reduced the need for rescue medication in young children with recurring wheezing illness.
Investigators evaluated respiratory viruses, atypical bacteria, and atopy on the severity of asthma and the effect on recovery.
The modifying effect of human rhinovirus on asthma exacerbation severity was examined in a pediatric population.
Patients with asthma were found to have higher blood eosinophil counts, fractional exhaled nitric oxide levels, and total serum IgE concentrations compared with patients with COPD.
Although some pregnant women discontinue their asthma medications for fear of fetal drug toxicity, they may be putting their babies at greater risk.
Researchers assessed the efficacy of a once-daily treatment option for controlled asthma.
Asthma exacerbations may be reduced with vitamin D supplementation.
Mortality rates and changes in mortality rates for chronic respiratory diseases in the United States varied by county, sex, and particular disease type.
Compared with fine particle inhaled corticosteroids, extrafine particle inhaled corticosteroids helped patients achieve asthma control.
Montelukast is associated with depression, aggression, and nightmares in children.
Patients with clinical markers of greater asthma severity may experience a more significant reduction of exacerbations when treated with omalizumab.
The European Respiratory Society and American Thoracic Society have released updated guidelines on the use of noninvasive ventilation for acute respiratory failure.
Asthma in elderly patients presents with increased airway obstruction and mixed inflammation, possibly representing a distinct phenotype.
Children who discontinue inhaled corticosteroids for well-controlled asthma may experience worsening symptoms.
A greater degree of sickness behavior and poorer asthma-related quality of life were both associated with poorer self-rated health in patients with allergic asthma.
Fluticasone furoate plus vilanterol therapy offers long-term asthma control without serious adverse events.
Early initiation of folic acid or prenatal vitamin supplementation may protect the offspring of mothers who have a history of atopy from adverse childhood respiratory outcomes.
Fewer than half of patients with asthma have received a pneumococcal vaccination.
Identifying gender-based differences in asthma follow-ups is crucial to understanding sex-based differences in health behaviors.
Good asthma control can improve fertility in women with asthma.
When children are breastfed for 6 months or less, the risk for asthma exacerbations decreases.
Diet and exercise appeared to improve asthma symptom control, overall fitness, and quality of life.
Researchers examined the efficacy of tezepelumab, a human monoclonal antibody, in treating moderate to severe asthma with non-eosinophilic inflammation.
After accounting for individual risk factors, living altitude is not associated with variability in COPD prevalence.
Pediatric patients with asthma are at the highest risk for adverse drug events, particularly with inhaled corticosteroids.
Oral corticosteroids did not reduce symptom severity or duration in patients with lower respiratory tract infections without asthma.
Adults with asthma benefit from tailoring interventions based on sputum eosinophils vs clinical symptoms.
Researchers analyzed over 2.1 million patient-years' worth of data to determine the impact of short-acting beta agonist use in asthma.
Participants received 70 mg of tezepelumab every 4 weeks throughout the study.
International trends in asthma mortality are useful for assessing the effect of treatment strategies on the burden of asthma.
A 2015 update from the 1990 Global Burden of Disease study reveals current prevalence and mortality of asthma and chronic obstructive pulmonary disease.
A new algorithm developed by the National Institute for Health and Care Excellence was not useful for diagnosing asthma in children and adolescents.
The pathogeneses of steroid insensitivity in severe, steroid-resistant asthma may unlock new potential treatments.
Asthma is associated with development of inflammatory bowel disease.
Fluticasone furoate and vilanterol combination therapy reduced both daytime and nighttime symptoms in patients with persistent uncontrolled asthma.
Elevated sputum eosinophil levels correlate with the severity of clinical outcomes in asthma.
A single-center study found that omalizumab led to reductions in allergic response much earlier than previously demonstrated.
Influenza vaccination provided a small protective effect in patients with asthma.
In children with allergic asthma and rhinitis, sublingual immunotherapy (SLIT) was shown to not only improve patient-reported symptoms, but also airway inflammation and pulmonary function.
Study outcomes provided insufficient evidence to support vitamin D supplementation for the prevention of atopy.
When pregnant women are exposed to certain air pollutants, the susceptibility to allergic asthma may increase across generations.
Moderate and severe asthma exacerbations were predictive of similar future events, and they appear to be phenotypically distinct conditions.
Allergic and nonallergic rhinitis guidelines include the latest updates from BSACI for diagnosing and managing children and adults.
When general practitioners refer patients to asthma diagnostic consultation services asthma diagnosis improved.
Intense exposure over the course of a single day has been linked to an elevated risk of developing chronic health conditions.
A study of 65 patients examined the efficacy of using serum periostin as a biomarker for asthma with comorbid upper airway disease.
Data were collected from 8956 mother-child pairs with children born between 1991 and 1992.
Azithromycin reduced exacerbations and improved quality of life in adults with asthma in a randomized double-blind placebo-controlled trial.
BMI is causally related to higher prevalence of asthma, but not hay fever or allergy.
Pro-inflammatory pathways associated with asthma reduce sepsis and sepsis related mortality in patients with infection.
Two phase 3 clinical development programs showed improved breathing in children and adolescents with moderate-to-severe asthma regardless of allergic status.
Testosterone blocks production of innate lymphoid cells, possibly explaining the gender disparity in asthma diagnoses.
A combination of several factors -- including electrical activity, high humidity, and rainfall -- can lead to asthma outbreaks in conjunction with thunderstorms.
Asthma risk increased when mothers required antidiabetic medication during pregnancy to manage either type 2 or gestational diabetes.
The most recent ERS guideline includes significant changes from prior recommendations in an effort to accommodate newer delivery devices.
The rise in asthma and allergy symptoms may be due to climate change which heightens the damage of airway cells by outdoor fungus.
Mepolizumab resulted in longer remission periods with a larger proportion of participants in remission compared to the placebo, which resulted in reduced glucocorticoid use.
Sublingual immunotherapy is associated with slower AR progression and less frequent asthma onset in patients with allergic rhinitis.
Prenatal exposure to ambient fine particulate matter and stress are linked to increased childhood asthma in boys by age 6 years.
Imatinib demonstrated an improvement in mast-cell activity and airway hyperresponsiveness in severe refractory asthma vs placebo.
Researchers compared 4- and 8-week benralizumab vs placebo for asthma.
Oxidative stress may play an important role in the development of recurrent wheezing following viral ARIs in infancy.
Data from the Generation R, SEATON, PACMAN, and BREATHE studies were analyzed to determine the link between asthma, asthma exacerbations, and childhood antibiotic use.
Compared to the year prior to bronchial thermoplasty (BT) treatment, in the 2 years after BT treatment, patients experienced reduction in severe exacerbations, hospitalizations, and ER visits.
More than 4 million women were included in an examination of the relationship between asthma and polycystic ovary syndrome.
Five studies collaboratively funded by the NIEHS, NHLBI, and NIAID explore ways of preventing and treating asthma.
A new study found no risks for exacerbation of asthma in children given LAIV, despite ACIP recommendations against its use in children with asthma.
Mepolizumab showed early and sustained clinically relevant improvements in quality of life, with a good safety profile in severe eosinophilic asthma.
The association between asthma and Rheumatoid arthritis can help identify high-risk patients and improve treatment options.
Treatment with antiasthma and antihistamine medication may help reduce migraine in this population.
Patients with asthma have an increased risk of pneumonia when using inhaled corticosteroids, including budesonide and fluticasone.
Oral corticosteroids, regardless of dose or duration, may increase the risk of adverse effects in patients with severe asthma.
AirDuo RespiClick and its authorized generic have been made available for the treatment of asthma
Study patients with late-onset asthma were 57% more likely to experience stroke, heart failure, myocardial infarction, or other CVD-related death.
In patients studied, 23% of patients with herpes zoster also had a history of asthma.